Preeclampsia Foundation is a patient-centered nonprofit organization focused on preeclampsia and related hypertensive disorders of pregnancy. Through philanthropy and partnerships, it channels charitable donations into concrete support for scientific research, clinical practice improvement, and public awareness initiatives designed to reduce illness and death among pregnant people and their babies.
Role of Preeclampsia Foundation in the funding ecosystem
The foundation operates as both an advocacy group and a grant-making body. A significant portion of its resources is dedicated to research funding, offered through competitive grant programs that support investigators studying the causes, prediction, prevention and treatment of preeclampsia. These grants help early‑stage and established researchers generate data, test new approaches and translate findings into better clinical care.
Types of grants and supported activities
- Research grants: Financial support for projects in basic, translational or clinical research focused on preeclampsia and hypertensive disorders of pregnancy.
- Clinical and quality‑of‑care projects: Support for initiatives that improve diagnosis, management and follow‑up of patients, including development or implementation of best‑practice protocols.
- Education and awareness efforts: Funding for professional education, patient information tools and public campaigns that increase recognition of warning signs and promote timely care.
Target audiences and typical applicants
Funding from Preeclampsia Foundation is generally aimed at researchers, clinicians and academic or hospital-based teams working in obstetrics, maternal–fetal medicine, epidemiology and related fields. Depending on the specific program, applicants may include early‑career investigators, multi‑disciplinary research consortia, or institutions piloting innovative care models for high‑risk pregnancies.
Impact and partnerships
By providing targeted research grants and project funding, the foundation helps fill gaps not always addressed by large public agencies, especially in early‑stage or high‑risk research areas. It often collaborates with universities, medical centers and other foundations to co‑fund awards, extend the reach of its programs and accelerate the translation of research results into practice. The overall aim is to reduce the global burden of preeclampsia through evidence‑based solutions, better informed clinicians and empowered patients.